Monthly Archives: September 2016
Two new articles in Tropical Diseases, Travel Medicine and Vaccines report on the efforts of the Global Alliance for Rabies Control and their tenth annual World Rabies Day, including the international goal of eliminating the public health threat of canine-transmitted rabies by the year 2030.
Overuse injuries such as stress fractures occur along a spectrum of severity which can make standardizing their treatment a challenge. Published as part of the Injuries in sport thematic series in the Journal of Orthopaedic Surgery, Dr. Timothy L. Miller’s article ‘Taking a Holistic Approach to Managing Difficult Stress Fractures’ provides an overview of the key points required for evaluating and treating athletes with these injuries. Here he tells us more about his article and looks back at injuries in the recent Olympic Games.
As World Alzheimer’s Month draws to a close, James Smith, Communications and Administration Coordinator at Alzheimer’s Disease International, highlights the challenges faced by people with dementia worldwide, explains what the campaign aims to achieve, and illustrates how this can be done.
Discrepancies in pediatric research reporting – from clinical trial registry record to published results
Previous studies have found discrepancies between what’s included in a clinical trial registry and what’s published in results papers. But to what extent does this affect pediatric research? New research published today in Trials investigated this concern and here, the lead author Paola Rosati discusses the results.
World Alzheimer’s Day is a campaign led by Alzheimer’s Disease International, aimed at raising awareness of Alzheimer’s Disease, and at tackling the misinformation surrounding it. As part of this, Alzheimer’s Research & Therapy presents a quiz on the disease and the research aimed at combatting it. How much do you know about Alzheimer’s Disease?
World leaders have committed to the prevention and treatment of Alzheimer’s Disease by 2025, but contemporary drug development is often slow. In this post, Dr. Jeffrey Cummings draws from his recent review in Alzheimer’s Research & Therapy to discuss how likely success will be, and suggests ways to make it more likely that this ambitious target will be met.2
The need for establishing core outcome sets for use in clinical trials is becoming well defined though special attention should be given to the instruments used for measuring these outcomes. Here, Cecilia Prinsen and Lidwine Mokkink, members of the COSMIN Steering Committee, discuss the implications and importance of a new consensus based guideline for selecting outcome measurement instruments, which published today in Trials.